Oligonucleotides targeting TCF4 triplet repeat expansion inhibit RNA foci and mis-splicing in Fuchs’ dystrophy

Abstract Fuchs’ endothelial corneal dystrophy (FECD) is the most common repeat expansion disorder. FECD impacts 4% of U.S. population and is the leading indication for corneal transplantation. Most cases are caused by an expanded intronic CUG tract in the TCF4 gene that forms nuclear foci, sequesters splicing factors and impairs splicing. We investigated the sense and antisense RNA landscape at the FECD gene and find that the sense-expanded repeat transcript is the predominant species in patient corneas. In patient tissue, sense foci number were negatively correlated with age and showed no correlation with sex. Each endothelial cell has ∼2 sense foci and each foci is single RNA molecule. We designed antisense oligonucleotides (ASOs) to target the mutant-repetitive RNA and demonstrated potent inhibition of foci in patient-derived cells. Ex vivo treatment of FECD human corneas effectively inhibits foci and reverses pathological changes in splicing. FECD has the potential to be a model for treating many trinucleotide repeat diseases and targeting the TCF4 expansion with ASOs represents a promising therapeutic strategy to prevent and treat FECD.

[1]  Anthony N Kuo,et al.  Descemet Membrane Endothelial Keratoplasty: Safety and Outcomes: A Report by the American Academy of Ophthalmology. , 2017, Ophthalmology.

[2]  C. Xing,et al.  Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy , 2017, Investigative ophthalmology & visual science.

[3]  Keith T. Gagnon,et al.  RNA biology of disease-associated microsatellite repeat expansions , 2017, Acta neuropathologica communications.

[4]  Y. Tan,et al.  Locked Nucleic Acid Gapmers and Conjugates Potently Silence ADAM33, an Asthma-Associated Metalloprotease with Nuclear-Localized mRNA , 2017, Molecular therapy. Nucleic acids.

[5]  anastasia. khvorova,et al.  The chemical evolution of oligonucleotide therapies of clinical utility , 2017, Nature Biotechnology.

[6]  D. Corey,et al.  c9orf72 Disease-Related Foci Are Each Composed of One Mutant Expanded Repeat RNA. , 2017, Cell chemical biology.

[7]  David R Corey,et al.  Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy , 2017, Nature Neuroscience.

[8]  A. Krieg,et al.  FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga , 2017, Nucleic acid therapeutics.

[9]  Eric T. Wang,et al.  Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat , 2017, RNA biology.

[10]  A. Jun,et al.  MicroRNA-29b Overexpression Decreases Extracellular Matrix mRNA and Protein Production in Human Corneal Endothelial Cells , 2016, Cornea.

[11]  J. Mehta,et al.  Five-Year Graft Survival Comparing Descemet Stripping Automated Endothelial Keratoplasty and Penetrating Keratoplasty. , 2016, Ophthalmology.

[12]  C. Xing,et al.  Correlation of Severity of Fuchs Endothelial Corneal Dystrophy With Triplet Repeat Expansion in TCF4. , 2015, JAMA ophthalmology.

[13]  K. Sobczak,et al.  Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy , 2015, Nucleic acids research.

[14]  R. Kittler,et al.  TCF4 Triplet Repeat Expansion and Nuclear RNA Foci in Fuchs' Endothelial Corneal Dystrophy. , 2015, Investigative ophthalmology & visual science.

[15]  Krishna R. Kalari,et al.  RNA Toxicity and Missplicing in the Common Eye Disease Fuchs Endothelial Corneal Dystrophy , 2015, The Journal of Biological Chemistry.

[16]  A. Jun,et al.  Transcript profile of cellular senescence-related genes in Fuchs endothelial corneal dystrophy. , 2014, Experimental eye research.

[17]  J. Mehta,et al.  Transethnic replication of association of CTG18.1 repeat expansion of TCF4 gene with Fuchs' corneal dystrophy in Chinese implies common causal variant. , 2014, Investigative ophthalmology & visual science.

[18]  D. Meller,et al.  Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study. , 2014, Ophthalmology.

[19]  D. Corey,et al.  Allele-Selective Inhibition of Mutant Atrophin-1 Expression by Duplex and Single-Stranded RNAs , 2014, Biochemistry.

[20]  C. Xing,et al.  Association and familial segregation of CTG18.1 trinucleotide repeat expansion of TCF4 gene in Fuchs' endothelial corneal dystrophy. , 2014, Investigative ophthalmology & visual science.

[21]  J. Rothstein,et al.  RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia , 2013, Proceedings of the National Academy of Sciences.

[22]  Kevin F. Bieniek,et al.  Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS , 2013, Acta Neuropathologica.

[23]  J. Watts.  Locked nucleic acid: tighter is different. , 2013, Chemical communications.

[24]  Nirubol Tosakulwong,et al.  A Common Trinucleotide Repeat Expansion within the Transcription Factor 4 (TCF4, E2-2) Gene Predicts Fuchs Corneal Dystrophy , 2012, PloS one.

[25]  R. Faragher,et al.  Characterization of cellular senescence mechanisms in human corneal endothelial cells , 2012, Aging cell.

[26]  T. Yorio,et al.  Perfusion-cultured bovine anterior segments as an ex vivo model for studying glucocorticoid-induced ocular hypertension and glaucoma. , 2011, Investigative ophthalmology & visual science.

[27]  J. Stein,et al.  Prevalence of corneal dystrophies in the United States: estimates from claims data. , 2011, Investigative ophthalmology & visual science.

[28]  David A. Price,et al.  Descemet's stripping endothelial keratoplasty five-year graft survival and endothelial cell loss. , 2011, Ophthalmology.

[29]  Brian B. Gibbens,et al.  Non-ATG–initiated translation directed by microsatellite expansions , 2010, Proceedings of the National Academy of Sciences.

[30]  D. Corey,et al.  Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism. , 2010, Chemistry & biology.

[31]  U. Jurkunas,et al.  Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy. , 2010, The American journal of pathology.

[32]  H. Soifer,et al.  Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents , 2009, Nucleic acids research.

[33]  Roni M. Shtein,et al.  Ophthalmic Technology Assessment Descemet ’ s Stripping Endothelial Keratoplasty : Safety and Outcomes , 2022 .

[34]  D. Corey,et al.  Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs , 2009, Nature Biotechnology.

[35]  N. Afshari,et al.  Clinical study of Fuchs corneal endothelial dystrophy leading to penetrating keratoplasty: a 30-year experience. , 2006, Archives of ophthalmology.

[36]  M. Swanson,et al.  Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. , 2004, Human molecular genetics.

[37]  W. Green,et al.  The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. , 2001, A M A Archives of Ophthalmology.

[38]  M. Baudrimont,et al.  Corneal endothelial cell apoptosis in patients with Fuchs' dystrophy. , 2000, Investigative ophthalmology & visual science.

[39]  F. McMahon,et al.  A novel, heritable, expanding CTG repeat in an intron of the SEF2-1 gene on chromosome 18q21.1. , 1997, Human molecular genetics.

[40]  A. Adamis,et al.  Fuchs' endothelial dystrophy of the cornea. , 1993, Survey of ophthalmology.

[41]  R. Tschumper,et al.  Human trabecular meshwork organ culture. A new method. , 1987, Investigative ophthalmology & visual science.

[42]  J. Krachmer,et al.  Corneal endothelial dystrophy. A study of 64 families. , 1978, Archives of ophthalmology.

[43]  M. Hogan,et al.  Fuchs' endothelial dystrophy of the cornea. 29th Sanford Gifford Memorial lecture. , 1974, American journal of ophthalmology.

[44]  H. Kaufman,et al.  Central cornea guttata. Incidence in the general population. , 1967, American journal of ophthalmology.

[45]  C. Teng,et al.  Histopathology of primary endothelial-epithelial dystrophy of the cornea. , 1958, American journal of ophthalmology.

[46]  Richard S Geary,et al.  Fomivirsen: clinical pharmacology and potential drug interactions. , 2002, Clinical pharmacokinetics.

[47]  D. Corey,et al.  Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. , 2001, Chemistry & biology.

[48]  Y. Shimizu,et al.  Human trabecular meshwork organ culture. , 1988, Japanese journal of ophthalmology.

[49]  F. Bigar.  Specular microscopy of the corneal endothelium. Optical solutions and clinical results. , 1982, Developments in ophthalmology.

[50]  F. Bigar.  Specular Microscopy of the Corneal Endothelium , 1982 .

[51]  R. Laing,et al.  Endothelial mosaic in Fuchs' dystrophy. A qualitative evaluation with the specular microscope. , 1981, Archives of ophthalmology.